Differentiated approach at the choice of chronic hepatitis C antiviral therapy mode (real clinical practice experience)
Aim of the study. To estimate efficacy and safety of cepeginterferon-alpha 2b (cPEG-IFNα2b) and ribavirin combination for the treatment of chronic hepatitis C (CHC), to define necessity of IL-28V genetic polymorphism diagnostics, to estimate liver elastometry scores at the background of antiviral th...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Russo |
| Cyhoeddwyd: |
Gastro LLC
2018-08-01
|
| Cyfres: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.gastro-j.ru/jour/article/view/216 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|